IL1A and rheumatoid arthritis: Excessive IL-1 production leads to pathological inflammation in autoimmune and autoinflammatory diseases such as rheumatoid arthritis (RA), systemic juvenile idiopathic arthritis (sJIA), and cryopyrin-associated periodic syndromes (CAPS) [2,3,4].